Clinical trial participation, clinical care, and patient outcomes by practice setting: a real-world database analysis of patients with Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma
Patients who received care in academic settings differed from those treated in the community; care in academic settings was associated with significantly longer OS and higher trial participation. Further research is warranted to better understand the factors that may contribute to the observed outcomes.
Authors
- Manoj Khanal (ORCID: https://orcid.org/0000-0001-7877-8849)
- Lisa M. Hess (ORCID: https://orcid.org/0000-0003-3631-3941)
- Maricer P. Escalón (ORCID: https://orcid.org/0000-0001-6454-0557)
- Katherine B. Winfree (ORCID: https://orcid.org/0000-0003-2088-1004)
- Xiaohong Li (ORCID: https://orcid.org/0000-0003-0959-3976)
- Débora S. Bruno
Institutions
- Eli Lilly (United States) (US)
- University Hospitals Cleveland Medical Center (US)
- Case Comprehensive Cancer Center
Publication Details
- Journal
- Hematology
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1080/16078454.2025.2457809
- Citations
- 2
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 3.25
Funders
- Eli Lilly and Company